InMode

InMode presents itself as a medical aesthetic technology brand whose technological advancements began over two decades ago with light, laser, and radiofrequency devices invented by leading doctors and scientists. The brand offers innovative workstations for providers, non-invasive and minimally-invasive options for patients, and hosts seminars and attends conferences throughout the year.

InMode states that its technological advancements began over two decades ago with state-of-the-art light, laser, and radiofrequency devices invented by leading doctors and scientists, who essentially launched and shaped the industry. The brand says its technology continues that legacy to provide superior satisfaction for both the patient and the practice.

Advanced medical aesthetic technology

• light, laser, and radiofrequency devices

  State-of-the-art devices invented by leading doctors and scientists.

• innovative workstations

  Workstations for providers to deliver superior results for patients.

• 2020.08.13

  Reported2020.08.13

  FDA clears InMode Morpheus8 Body handpiece and platform[2]FDA批准InMode Morpheus8 Body手具及平台prnewswire.com

  InMode announced that it had received FDA clearance to market the Morpheus8 Body handpiece and Morpheus8 Platform.

• 2020.02.18

  Reported2020.02.18

  InMode reports fourth-quarter and full-year 2019 results[3]InMode公布2019年第四季度及全年业绩prnewswire.com

  InMode announced financial results for the fourth quarter and full year ended December 31, 2019, reporting quarterly revenue of $47 million and full-year revenue of $156.4 million.

• 2020.01.21

  Reported2020.01.21

  InMode launches Evolve platform[4]InMode推出Evolve平台prnewswire.com

  InMode introduced Evolve, a non-invasive hands-free workstation designed to remodel skin, treat adipose tissue, and tone muscles.

• 2020.01.20

  Reported2020.01.20

  bodySCULPT introduces InMode EVOKE and EVOLVE treatments[5]bodySCULPT引入InMode EVOKE和EVOLVE疗程prnewswire.com

  bodySCULPT announced that it was among the first U.S. plastic surgery centers to introduce InMode's EVOKE facial-remodeling device and EVOLVE body-contouring treatments.

Read more

1. 1InMode - Advanced Medical Aesthetic Technologyinmodemd.com
2. 2FDA批准InMode Morpheus8 Body手具及平台prnewswire.com
3. 3InMode公布2019年第四季度及全年业绩prnewswire.com
4. 4InMode推出Evolve平台prnewswire.com
5. 5bodySCULPT引入InMode EVOKE和EVOLVE疗程prnewswire.com
6. 6InMode Reports First Quarter 2020 Financial Results; Quarterly Revenues of $40.4 Million Represent 32% Year over Year Growthprnewswire.com
7. 7InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growthprnewswire.com
8. 8InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growthprnewswire.com
9. 9InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63prnewswire.com
10. 10InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020prnewswire.com
11. 11InMode Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $30.8 Million, GAAP and *Non-GAAP Diluted Earnings per Share of $0.21 and $0.24prnewswire.com